ArticleCancer chemotherapy and pharmacology2016
Understanding the role of tariquidar, a potent Pgp inhibitor, in combination trials with cytotoxic drugs: What is missing?
Nuggehally R SrinivasPubMed ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it